Detalhe da pesquisa
1.
Serelaxin improves the therapeutic efficacy of RXFP1-expressing human amnion epithelial cells in experimental allergic airway disease.
Clin Sci (Lond)
; 130(23): 2151-2165, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27647937
2.
Radiologic response to MEK inhibition in a patient with a WNT-activated craniopharyngioma.
Pediatr Blood Cancer
; 68(3): e28753, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33073916
3.
Characterization of a novel model incorporating airway epithelial damage and related fibrosis to the pathogenesis of asthma.
Lab Invest
; 94(12): 1326-39, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25264707
4.
Atrial Fibrillation and Obesity: Reverse Remodeling of Atrial Substrate With Weight Reduction.
JACC Clin Electrophysiol
; 7(5): 630-641, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33640353
5.
Serelaxin enhances the therapeutic effects of human amnion epithelial cell-derived exosomes in experimental models of lung disease.
Br J Pharmacol
; 176(13): 2195-2208, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30883698
6.
Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease.
Stem Cell Res
; 15(3): 495-505, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26426509
7.
Methodological survey of designed uneven randomization trials (DU-RANDOM): a protocol.
Trials
; 15: 33, 2014 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24456965